{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:42:50Z","timestamp":1775234570414,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["18-74-00120"],"award-info":[{"award-number":["18-74-00120"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00432-020-03378-5","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T08:04:21Z","timestamp":1599897861000},"page":"49-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors"],"prefix":"10.1007","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5653-1105","authenticated-orcid":false,"given":"Olga Y.","family":"Burenina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia L.","family":"Lazarevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna F.","family":"Kustova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria A.","family":"Shavochkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina A.","family":"Moroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolay E.","family":"Kudashkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriy I.","family":"Patyutko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey V.","family":"Metelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard F.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry A.","family":"Skvortsov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timofei S.","family":"Zatsepin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria P.","family":"Rubtsova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga A.","family":"Dontsova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"3378_CR1","first-page":"647","volume":"25","author":"RA Allen","year":"1949","unstructured":"Allen RA, Lisa JR (1949) Combined liver cell and bile duct carcinoma. Am J Pathol 25:647\u2013655","journal-title":"Am J Pathol"},{"key":"3378_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ (2018) Non-coding RNA networks in cancer. Nat Rev Cancer 18:5\u201318. https:\/\/doi.org\/10.1038\/nrc.2017.99","journal-title":"Nat Rev Cancer"},{"key":"3378_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000471807","volume":"93","author":"E Bagirsakci","year":"2017","unstructured":"Bagirsakci E, Sahin E, Atabey N, Erdal E, Guerra V, Carr BI (2017) Role of albumin in growth inhibition in hepatocellular carcinoma. Oncology 93:136\u2013142. https:\/\/doi.org\/10.1159\/000471807","journal-title":"Oncology"},{"key":"3378_CR4","doi-asserted-by":"publisher","first-page":"7243968","DOI":"10.1155\/2017\/7243968","volume":"2017","author":"L Bolha","year":"2017","unstructured":"Bolha L, Ravnik-Glavac M, Glavac D (2017) Long noncoding RNAs as biomarkers in cancer. Dis Markers 2017:7243968. https:\/\/doi.org\/10.1155\/2017\/7243968","journal-title":"Dis Markers"},{"key":"3378_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5301\/ijbm.5000300","volume":"32","author":"BI Carr","year":"2017","unstructured":"Carr BI, Guerra V (2017) Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients. Int J Biol Markers 32:391\u2013396. https:\/\/doi.org\/10.5301\/ijbm.5000300","journal-title":"Int J Biol Markers"},{"key":"3378_CR6","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/cells8091015","volume":"8","author":"Y Chi","year":"2019","unstructured":"Chi Y, Wang D, Wang J, Yu W, Yang J (2019) Long non-coding RNA in the pathogenesis of cancers. Cells 8:1015. https:\/\/doi.org\/10.3390\/cells8091015","journal-title":"Cells"},{"key":"3378_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13304-013-0222-3","volume":"66","author":"A Cristiano","year":"2014","unstructured":"Cristiano A, Dietrich A, Spina JC, Ardiles V, De Santibanes E (2014) Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updates Surg 66:9\u201321. https:\/\/doi.org\/10.1007\/s13304-013-0222-3","journal-title":"Updates Surg"},{"key":"3378_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/cancers11030409","volume":"11","author":"I Cristobal","year":"2019","unstructured":"Cristobal I, Sanz-Alvarez M, Luque M, Carames C, Rojo F, Garcia-Foncillas J (2019) The role of microRNAs in hepatoblastoma tumors. Cancers (Basel) 11:409. https:\/\/doi.org\/10.3390\/cancers11030409","journal-title":"Cancers (Basel)"},{"key":"3378_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.dld.2018.08.019","volume":"11","author":"F De Stefano","year":"2018","unstructured":"De Stefano F, Chacon E, Turcios L, Marti F, Gedaly R (2018) Novel biomarkers in hepatocellular carcinoma. Dig Liver Dis 11:1115\u20131123. https:\/\/doi.org\/10.1016\/j.dld.2018.08.019","journal-title":"Dig Liver Dis"},{"key":"3378_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/HMER.S16316","volume":"4","author":"R Dhanasekaran","year":"2012","unstructured":"Dhanasekaran R, Limaye A, Cabrera R (2012) Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med 4:19\u201337. https:\/\/doi.org\/10.2147\/HMER.S16316","journal-title":"Hepat Med"},{"key":"3378_CR11","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.3748\/wjg.v23.i29.5282","volume":"23","author":"D Dimitroulis","year":"2017","unstructured":"Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E et al (2017) From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World J Gastroenterol 23:5282\u20135294. https:\/\/doi.org\/10.3748\/wjg.v23.i29.5282","journal-title":"World J Gastroenterol"},{"key":"3378_CR12","doi-asserted-by":"publisher","first-page":"BSR20180915","DOI":"10.1042\/BSR20180915","volume":"38","author":"B Ding","year":"2018","unstructured":"Ding B, Lou W, Xu L, Fan W (2018) Non-coding RNA in drug resistance of hepatocellular carcinoma. Biosci Rep 38:BSR20180915. https:\/\/doi.org\/10.1042\/BSR20180915","journal-title":"Biosci Rep"},{"key":"3378_CR13","doi-asserted-by":"publisher","first-page":"31862","DOI":"10.7717\/peerj.3575","volume":"7","author":"DD Esposti","year":"2016","unstructured":"Esposti DD, Hernandez-Vargas H, Voegele C, Fernandez-Jimenez N, Forey N, Bancel B et al (2016) Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing. Oncotarget 7:31862\u201331877. https:\/\/doi.org\/10.7717\/peerj.3575","journal-title":"Oncotarget"},{"key":"3378_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1515\/cclm-2018-0803","volume":"57","author":"S Ferraro","year":"2019","unstructured":"Ferraro S, Panzeri A, Braga F, Panteghini M (2019) Serum \u03b1-fetoprotein in pediatric oncology: not a children\u2019s tale. Clin Chem Lab Med 57:783\u2013797. https:\/\/doi.org\/10.1515\/cclm-2018-0803","journal-title":"Clin Chem Lab Med"},{"key":"3378_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2016.05.030","volume":"379","author":"D Gu","year":"2016","unstructured":"Gu D, Jin H, Jin G, Wang C, Wang N, Hu F et al (2016) The asialoglycoprotein receptor suppresses the metastasis of hepatocellular carcinoma via LASS2-mediated inhibition of V-ATPase activity. Cancer Lett 379:107\u2013116. https:\/\/doi.org\/10.1016\/j.canlet.2016.05.030","journal-title":"Cancer Lett"},{"key":"3378_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5009\/gnl17277","volume":"12","author":"HG Hass","year":"2018","unstructured":"Hass HG, Vogel U, Scheurlen M, Jobst J (2018) Subclassification and detection of new markers for the discrimination of primary liver tumors by gene expression analysis using oligonucleotide arrays. Gut Liver 12:306\u2013315. https:\/\/doi.org\/10.5009\/gnl17277","journal-title":"Gut Liver"},{"key":"3378_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2019.02.033","volume":"450","author":"J He","year":"2019","unstructured":"He J, Zuo Q, Hu B, Jin H, Wang C, Cheng Z et al (2019) A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Lett 450:98\u2013109. https:\/\/doi.org\/10.1016\/j.canlet.2019.02.033","journal-title":"Cancer Lett"},{"key":"3378_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/hep4.1029","volume":"1","author":"E Indersie","year":"2017","unstructured":"Indersie E, Lesjean S, Hooks KB, Sagliocco F, Ernault T, Cairo S et al (2017) MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting \u03b2-catenin and Wnt signaling. Hepatol Commun 1:168\u2013183. https:\/\/doi.org\/10.1002\/hep4.1029","journal-title":"Hepatol Commun"},{"key":"3378_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cca.2019.04.082","volume":"495","author":"N Jiang","year":"2019","unstructured":"Jiang N, Pan J, Fang S, Zhou C, Han Y, Chen J et al (2019) Liquid biopsy: circulating exosomal long noncoding RNAs in cancer. Clin Chim Acta 495:331\u2013337. https:\/\/doi.org\/10.1016\/j.cca.2019.04.082","journal-title":"Clin Chim Acta"},{"key":"3378_CR20","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1136\/gutjnl-2011-301748","volume":"61","author":"SA Khan","year":"2012","unstructured":"Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP et al (2012) Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut 61:1657\u20131669. https:\/\/doi.org\/10.1136\/gutjnl-2011-301748","journal-title":"Gut"},{"key":"3378_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jhep.2017.04.009","volume":"67","author":"M Klingenberg","year":"2017","unstructured":"Klingenberg M, Matsuda A, Diederichs S, Patel T (2017) Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets. J Hepatol 67:603\u2013618. https:\/\/doi.org\/10.1016\/j.jhep.2017.04.009","journal-title":"J Hepatol"},{"key":"3378_CR22","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-3402515","author":"M Komuta","year":"2019","unstructured":"Komuta M, Yeh MM (2019) A review on the update of combined hepatocellular cholangiocarcinoma. Semin Liver Dis. https:\/\/doi.org\/10.1055\/s-0039-3402515","journal-title":"Semin Liver Dis"},{"key":"3378_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cas.12854","volume":"107","author":"H Konishi","year":"2016","unstructured":"Konishi H, Ichikawa D, Yamamoto Y, Arita T, Shoda K, Hiramoto HPL et al (2016) Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma. Cancer Sci 107:149\u2013154. https:\/\/doi.org\/10.1111\/cas.12854","journal-title":"Cancer Sci"},{"key":"3378_CR24","doi-asserted-by":"publisher","first-page":"125094","DOI":"10.1155\/2015\/125094","volume":"201","author":"H Lan","year":"2015","unstructured":"Lan H, Lu H, Wang X, Jin H (2015) MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed Res Int 201:125094. https:\/\/doi.org\/10.1155\/2015\/125094","journal-title":"Biomed Res Int"},{"key":"3378_CR25","doi-asserted-by":"publisher","first-page":"17113","DOI":"10.1002\/jcp.28470","volume":"234","author":"J Li","year":"2019","unstructured":"Li J, Huang L, Li Z, Zhong X, Tai S, Jiang X et al (2019a) Functions and roles of long noncoding RNA in cholangiocarcinoma. J Cell Physiol 234:17113\u201317126. https:\/\/doi.org\/10.1002\/jcp.28470","journal-title":"J Cell Physiol"},{"key":"3378_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3892\/etm.2019.7564","volume":"18","author":"O Li","year":"2019","unstructured":"Li O, Yi W, Yang P, Guo C, Peng C (2019b) Long non-coding RNA UCA1 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells through targeting microRNA-122. Exp Ther Med 18:25\u201332. https:\/\/doi.org\/10.3892\/etm.2019.7564","journal-title":"Exp Ther Med"},{"key":"3378_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/children6010001","volume":"6","author":"IIP Lim","year":"2018","unstructured":"Lim IIP, Bondoc AJ, Geller JI, Tiao GM (2018) Hepatoblastoma\u2014the evolution of biology, surgery, and transplantation. Children (Basel) 6:1. https:\/\/doi.org\/10.3390\/children6010001","journal-title":"Children (Basel)"},{"key":"3378_CR28","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1158\/0008-5472.CAN-19-0255","volume":"79","author":"L Lim","year":"2019","unstructured":"Lim L, Wong SYS, Huang F, Lim S, Chong SS, Ooi LL et al (2019) Roles and regulation of long noncoding RNAs in hepatocellular carcinoma. Cancer Res 79:5131\u20135139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0255","journal-title":"Cancer Res"},{"key":"3378_CR29","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.3748\/wjg.v20.i20.6314","volume":"20","author":"WT Liu","year":"2014","unstructured":"Liu WT, Lu X, Tang GH, Ren JJ, Liao WJ, Ge PL et al (2014) LncRNAs expression signatures of hepatocellular carcinoma revealed by microarray. World J Gastroenterol 20:6314\u20136321. https:\/\/doi.org\/10.3748\/wjg.v20.i20.6314","journal-title":"World J Gastroenterol"},{"key":"3378_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature10888","volume":"482","author":"A Lujambio","year":"2012","unstructured":"Lujambio A, Lowe SW (2012) The microcosmos of cancer. Nature 482:347\u2013355. https:\/\/doi.org\/10.1038\/nature10888","journal-title":"Nature"},{"key":"3378_CR31","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.2147\/OTT.S136915","volume":"10","author":"Z Ma","year":"2017","unstructured":"Ma Z, Huang H, Xu Y, He X, Wang J, Hui B et al (2017) Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors. OncoTargets Ther 10:4711\u20134717. https:\/\/doi.org\/10.2147\/OTT.S136915","journal-title":"OncoTargets Ther"},{"key":"3378_CR32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1200\/EDBK_200939","volume":"38","author":"LY Mak","year":"2018","unstructured":"Mak LY, Cruz-Ramon V, Chinchilla-Lopez P, Torres HA, LoConte NK, Rice JP et al (2018) Global Epidemiology, prevention, and management of hepatocellular carcinoma. Am Soc Clin Oncol Educ Book 38:262\u2013279. https:\/\/doi.org\/10.1200\/EDBK_200939","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"3378_CR33","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1478-3231.2005.01100.x","volume":"25","author":"XB Man","year":"2005","unstructured":"Man XB, Tang L, Zhang BH, Li SJ, Qiu XH, Wu MC et al (2005) Upregulation of glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers. Liver Int 25:962\u2013966. https:\/\/doi.org\/10.1111\/j.1478-3231.2005.01100.x","journal-title":"Liver Int"},{"key":"3378_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd.2016.117","volume":"16","author":"M Matsui","year":"2017","unstructured":"Matsui M, Corey DR (2017) Non-coding RNAs as drug targets. Nat Rev Drug Discov 16:167\u2013179. https:\/\/doi.org\/10.1038\/nrd.2016.117","journal-title":"Nat Rev Drug Discov"},{"key":"3378_CR35","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1111\/cas.13352","volume":"108","author":"A Misawa","year":"2017","unstructured":"Misawa A, Takayama KI, Inoue S (2017) Long non-coding RNAs and prostate cancer. Cancer Sci 108:2107\u20132114. https:\/\/doi.org\/10.1111\/cas.13352","journal-title":"Cancer Sci"},{"key":"3378_CR36","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cld.2018.06.008","volume":"22","author":"K Ng","year":"2018","unstructured":"Ng K, Mogul DB (2018) Pediatric liver tumors. Clin Liver Dis 22:753\u2013772. https:\/\/doi.org\/10.1016\/j.cld.2018.06.008","journal-title":"Clin Liver Dis"},{"key":"3378_CR37","doi-asserted-by":"publisher","first-page":"113638","DOI":"10.1016\/j.bcp.2019.113638","volume":"169","author":"B Ning","year":"2019","unstructured":"Ning B, Yu D, Yu AM (2019) Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics. Biochem Pharmacol 169:113638. https:\/\/doi.org\/10.1016\/j.bcp.2019.113638","journal-title":"Biochem Pharmacol"},{"key":"3378_CR38","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/cancers11081170","volume":"11","author":"B Pardini","year":"2019","unstructured":"Pardini B, Sabo AA, Birolo G, Calin GA (2019) Noncoding RNAs in extracellular fluids as cancer biomarkers: the new frontier of liquid biopsies. Cancers (Basel) 11:1170. https:\/\/doi.org\/10.3390\/cancers11081170","journal-title":"Cancers (Basel)"},{"key":"3378_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.lfs.2017.10.007","volume":"191","author":"L Qiu","year":"2017","unstructured":"Qiu L, Tang Q, Li G, Chen K (2017) Long non-coding RNAs as biomarkers and therapeutic targets: recent insights into hepatocellular carcinoma. Life Sci 191:273\u2013282. https:\/\/doi.org\/10.1016\/j.lfs.2017.10.007","journal-title":"Life Sci"},{"key":"3378_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan S, Hallemeier CL, Kelley RK, Gores GJ (2018) Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15:95\u2013111. https:\/\/doi.org\/10.1038\/nrclinonc.2017.157","journal-title":"Nat Rev Clin Oncol"},{"key":"3378_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3350\/cmh.2016.0101","volume":"22","author":"M Roncalli","year":"2016","unstructured":"Roncalli M, Sciarra A, Tommaso LD (2016) Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma. Clin Mol Hepatol 22:199\u2013211. https:\/\/doi.org\/10.3350\/cmh.2016.0101","journal-title":"Clin Mol Hepatol"},{"key":"3378_CR42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fgene.2015.00196","volume":"6","author":"A Shahryari","year":"2015","unstructured":"Shahryari A, Jazi MS, Samaei NM, Mowla SJ (2015) Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis. Front Genet 6:196. https:\/\/doi.org\/10.3389\/fgene.2015.00196","journal-title":"Front Genet"},{"key":"3378_CR43","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1369\/0022155413503662","volume":"61","author":"B Shi","year":"2013","unstructured":"Shi B, Abrams M, Sepp-Lorenzino L (2013) Expression of asialoglycoprotein receptor 1 in human hepatocellular carcinoma. J Histochem Cytochem 61:901\u2013909. https:\/\/doi.org\/10.1369\/0022155413503662","journal-title":"J Histochem Cytochem"},{"key":"3378_CR44","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM (2019) The role of non-coding RNAs in oncology. Cell 179:1033\u20131055. https:\/\/doi.org\/10.1016\/j.cell.2019.10.017","journal-title":"Cell"},{"key":"3378_CR45","doi-asserted-by":"publisher","first-page":"16142","DOI":"10.1038\/s41598-017-16260-1","volume":"7","author":"F Sonohara","year":"2017","unstructured":"Sonohara F, Inokawa Y, Hayashi M, Yamada S, Sugimoto H Fujii et al (2017) Prognostic value of long non-coding RNA HULC and MALAT1 following the curative resection of hepatocellular carcinoma. Sci Rep 7:16142. https:\/\/doi.org\/10.1038\/s41598-017-16260-1","journal-title":"Sci Rep"},{"key":"3378_CR46","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1002\/jcb.25862","volume":"11","author":"X Tan","year":"2017","unstructured":"Tan X, Huang Z, Li X (2017) Long non-coding RNA MALAT1 interacts with miR-204 to modulate human hilar cholangiocarcinoma proliferation, migration, and invasion by targeting CXCR4. J Cell Biochem 11:3643\u20133653. https:\/\/doi.org\/10.1002\/jcb.25862","journal-title":"J Cell Biochem"},{"key":"3378_CR47","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1373\/clinchem.2018.301150","volume":"65","author":"C Tan","year":"2019","unstructured":"Tan C, Cao J, Chen L, Xi X, Wang S, Zhu Y et al (2019) Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma. Clin Chem 65:905\u2013915. https:\/\/doi.org\/10.1373\/clinchem.2018.301150","journal-title":"Clin Chem"},{"key":"3378_CR48","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.3748\/wjg.v21.i37.10573","volume":"21","author":"N Tsuchiya","year":"2015","unstructured":"Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T (2015) Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol 21:10573\u201310583. https:\/\/doi.org\/10.3748\/wjg.v21.i37.10573","journal-title":"World J Gastroenterol"},{"key":"3378_CR49","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/ijc.32277","volume":"146","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang X, Chen W, Hu X, Li J, Liu C (2020) Regulatory roles of long noncoding RNAs implicated in cancer hallmarks. Int J Cancer 146:906\u2013916. https:\/\/doi.org\/10.1002\/ijc.32277","journal-title":"Int J Cancer"},{"key":"3378_CR50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-019-1086-z","volume":"25","author":"L Wei","year":"2019","unstructured":"Wei L, Wang X, Lv L, Liu J, Xing H, Song Y et al (2019) The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Mol Cancer 25:147. https:\/\/doi.org\/10.1186\/s12943-019-1086-z","journal-title":"Mol Cancer"},{"key":"3378_CR51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrgastro.2017.169","volume":"15","author":"CM Wong","year":"2018","unstructured":"Wong CM, Tsang FHC, Ng IOL (2018) Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications. Nat Rev Gastroenterol Hepatol 15:137\u2013151. https:\/\/doi.org\/10.1038\/nrgastro.2017.169","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3378_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biopha.2017.05.061","volume":"92","author":"Y Xu","year":"2017","unstructured":"Xu Y, Wang Z, Jiang X, Cui Y (2017a) Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition. Biomed Pharmacother 92:17\u201323. https:\/\/doi.org\/10.1016\/j.biopha.2017.05.061","journal-title":"Biomed Pharmacother"},{"key":"3378_CR53","doi-asserted-by":"publisher","first-page":"96203","DOI":"10.18632\/oncotarget.21884","volume":"8","author":"Y Xu","year":"2017","unstructured":"Xu Y, Yao Y, Leng K, Li Z, Qin W, Zhong X et al (2017b) Long non-coding RNA UCA1 indicates an unfavorable prognosis and promotes tumorigenesis via regulating AKT\/GSK-3\u03b2 signaling pathway in cholangiocarcinoma. Oncotarget 8:96203\u201396214. https:\/\/doi.org\/10.18632\/oncotarget.21884","journal-title":"Oncotarget"},{"key":"3378_CR54","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ccell.2019.04.007","volume":"35","author":"R Xue","year":"2019","unstructured":"Xue R, Chen L, Zhang C, Fujita M, Li R, Yan SM et al (2019) Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes. Cancer Cell 35:932\u2013947. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.007","journal-title":"Cancer Cell"},{"key":"3378_CR55","doi-asserted-by":"publisher","first-page":"191029","DOI":"10.1155\/2015\/191029","volume":"2015","author":"Z Yang","year":"2015","unstructured":"Yang Z, Lu Y, Xu Q, Tang B, Park CK, Chen X (2015) HULC and H19 played different roles in overall and disease-free survival from hepatocellular carcinoma after curative hepatectomy: a preliminary analysis from gene expression omnibus. Dis Markers 2015:191029. https:\/\/doi.org\/10.1155\/2015\/191029","journal-title":"Dis Markers"},{"key":"3378_CR56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/jcmm.12956","volume":"21","author":"X Yu","year":"2017","unstructured":"Yu X, Zheng H, Chan MT, Wu WK (2017) HULC: an oncogenic long non-coding RNA in human cancer. Cell Mol Med 21:410\u2013417. https:\/\/doi.org\/10.1111\/jcmm.12956","journal-title":"Cell Mol Med"},{"key":"3378_CR57","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000484589","volume":"44","author":"W Yuan","year":"2017","unstructured":"Yuan W, Sun Y, Liu L, Zhou B, Wang S, Gu D (2017) Circulating lncRNAs serve as diagnostic markers for hepatocellular carcinoma. Cell Physiol Biochem 44:125\u2013132. https:\/\/doi.org\/10.1159\/000484589","journal-title":"Cell Physiol Biochem"},{"key":"3378_CR58","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00438-015-1163-y","volume":"291","author":"L Zhang","year":"2016","unstructured":"Zhang L, Liu X, Zhang X, Chen R (2016a) Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets. Mol Genet Genomics 291:1035\u20131051. https:\/\/doi.org\/10.1007\/s00438-015-1163-y","journal-title":"Mol Genet Genomics"},{"key":"3378_CR59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.canlet.2015.09.008","volume":"379","author":"H Zhang","year":"2016","unstructured":"Zhang H, Yang T, Wu M, Shen F (2016b) Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett 379:198\u2013205. https:\/\/doi.org\/10.1016\/j.canlet.2015.09.008","journal-title":"Cancer Lett"},{"key":"3378_CR60","doi-asserted-by":"publisher","first-page":"45932","DOI":"10.1038\/srep45932","volume":"7","author":"S Zhou","year":"2017","unstructured":"Zhou S, O\u2019Gorman MR, Yang F, Andresen K, Wang L (2017) Glypican 3 as a serum marker for hepatoblastoma. Sci Rep 7:45932. https:\/\/doi.org\/10.1038\/srep45932","journal-title":"Sci Rep"},{"key":"3378_CR61","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/med.21455","volume":"38","author":"F Zhou","year":"2018","unstructured":"Zhou F, Shang W, Yu X, Tian J (2018) Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment. Med Res Rev 38:741\u2013767. https:\/\/doi.org\/10.1002\/med.21455","journal-title":"Med Res Rev"},{"key":"3378_CR62","doi-asserted-by":"publisher","first-page":"94997","DOI":"10.18632\/oncotarget.22031","volume":"8","author":"Y Zou","year":"2017","unstructured":"Zou Y, Li J, Chen Y, Xiao H, Zhang F, Yu D et al (2017) BANCR: a novel oncogenic long non-coding RNA in human cancers. Oncotarget 8:94997\u201395004. https:\/\/doi.org\/10.18632\/oncotarget.22031","journal-title":"Oncotarget"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03378-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03378-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03378-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T00:51:18Z","timestamp":1631407878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03378-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["3378"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03378-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]},"assertion":[{"value":"1 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest neither competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We confirm that all experiments involving human liver samples were approved by medical ethics committee of our institutions. All procedures were performed in accordance with Declaration of Helsinki (1964) and its later amendments (World Medical Association, 2013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent for the use of tissue samples for scientific purposes was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}